Hepatic ablation for neuroendocrine tumor metastases

Journal of Surgical Oncology

Volumn 100, Issue 8, 2009, Pages 635-638

  Maithel, Shishir K ^a   Fong, Yuman ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cytoreductive surgery; Hepatic metastases; Neuroendocrine tumor; Radiofrequency ablation

Indexed keywords

ACUTE KIDNEY FAILURE; ARTIFICIAL EMBOLISM; BLEEDING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CYTOREDUCTION; DISEASE COURSE; HEPATIC ABLATION; HUMAN; INCIDENCE; LIVER METASTASIS; LUNG EMBOLISM; METASTASIS; MORBIDITY; NEUROENDOCRINE TUMOR; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR VOLUME;

CATHETER ABLATION; HUMANS; LIVER NEOPLASMS; NEUROENDOCRINE TUMORS;

EID: 73449148359     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21196     Document Type: Review

References (23)

1. Siperstein AE, Berber E: Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases. World J Surg 2001;25:693-696.
2. Atwell TD, Charboneau JW, Que FG, et al.: Treatment of neuroendocrine cancer metastatic to the liver: The role of ablative techniques. Cardiovasc Intervent Radiol 2005;28:409-421.
3. Pollock RE, Roth JA: Cancer-induced immunosuppression: Implications for therapy? Semin Surg Oncol 1989;5:414-419.
4. Jarnagin WR, Gonen M, Fong Y, et al.: Improvement in perioperative outcome after hepatic resection: Analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002;236:397-406 discussion 406-7.
5. Decadt B, Siriwardena AK: Radiofrequency ablation of liver tumours: Systematic review. Lancet Oncol 2004;5:550-560.
6. Osborne DA, Zervos EE, Strosberg J, et al.: Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors. Ann Surg Oncol 2006;13:572-581.
7. Chamberlain RS, Canes D, Brown KT, et al.: Hepatic neuroendocrine metastases: Does intervention alter outcomes? J Am Coll Surg 2000;190:432-445.
8. Norton JA, Warren RS, Kelly MG, et al.: Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery 2003;134:1057-1063 discussion 1063-5.
9. Sarmiento JM, Heywood G, Rubin J, et al.: Surgical treatment of neuroendocrine metastases to the liver: A plea for resection to increase survival. J Am Coll Surg 2003;197:29-37.
10. Que FG, Nagorney DM, Batts KP, et al.: Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 1995;169:36-42 discussion 42-3.
11. Mazzaglia PJ, Berber E, Siperstein AE: Radiofrequency thermal ablation of metastatic neuroendocrine tumors in the liver. Curr Treat Options Oncol 2007;8:322-330.
12. Eriksson J, Stalberg P, Nilsson A, et al.: Radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors. World J Surg 2008; 32:930-938.
13. Berber E, Flesher N, Siperstein AE: Laparoscopic radiofrequency ablation of neuroendocrine liver metastases. World J Surg 2002;26:985-990.
14. Veenendaal LM, Borel Rinkes IH, Lips CJ, et al.: Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy. World J Surg Oncol 2006;4:35.
15. Gillams AR: Liver ablation therapy. Br J Radiol 2004;77:713-723.
16. Seifert JK, Cozzi PJ, Morris DL: Cryotherapy for neuroendocrine liver metastases. Semin Surg Oncol 1998;14:175-183.
17. Poon RT, Ng KK, Lam CM, et al.: Learning curve for radiofrequency ablation of liver tumors: Prospective analysis of initial 100 patients in a tertiary institution. Ann Surg 2004;239: 441-449.
18. Mazzaglia PJ, Berber E, Milas M, et al.: Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: A 10-year experience evaluating predictors of survival. Surgery 2007; 142:10-19.
19. Dousset B, Saint-Marc O, Pitre J, et al.: Metastatic endocrine tumors: Medical treatment, surgical resection, or liver transplantation. World J Surg 1996;20:908-914 discussion 914-5.
20. Chen H, Hardacre JM, Uzar A, et al.: Isolated liver metastases from neuroendocrine tumors: Does resection prolong survival? J Am Coll Surg 1998;187:88-92 discussion 92-3.
21. Jaeck D, Oussoultzoglou E, Bachellier P, et al.: Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: Safe hepatic surgery. World J Surg 2001;25:689-692.
22. Nave H, Mossinger E, Feist H, et al.: Surgery as primary treatment in patients with liver metastases from carcinoid tumors: A retrospective, unicentric study over 13 years. Surgery 2001;129: 170-175.
23. Touzios JG, Kiely JM, Pitt SC, et al.: Neuroendocrine hepatic metastases: Does aggressive management improve survival? Ann Surg 2005;241:776-783. discussion 783-5.